Pushpendra Singh | Senior Director, Head of Product Development
Ocugen

Pushpendra Singh, Senior Director, Head of Product Development, Ocugen

Experienced drug development leader with expertise in advancing cell and gene therapies, biologics, and vaccines from preclinical to late phase clinical stages: successfully led five diverse programs using a cross-functional matrix team approach. I specialized in ophthalmology, infectious diseases, and orthopedics, with a strong track record in regulatory compliance, CDMO collaboration, vendor management and CMC manufacturing oversight. Recognized for scientific leadership through global presentations, workshops, and contributions to innovative therapies addressing unmet medical needs.

Appearances:



Advanced Therapies USA 2025 - Day 1 @ 15:35

Process development and validation strategy for gene therapy

Advanced Therapies USA 2025 - Day 2 @ 14:05

Panel Discussion: Understanding the Evolving Landscape of Viral Vector

last published: 16/Sep/25 16:07 GMT

back to speakers

Get Involved with the Advanced Therapies Congress

 

To sponsor or exhibit

Natasha Bangle
natasha.bangle@terrapinn.com
+44 20 3545 5515

 

To speak

Chris Shanks
chris.shanks@terrapinn.com
+44 20 8152 7604